{"id":"W2030193153","doi":"10.1097/jto.0b013e31822f657a","title":"Erlotinib or Docetaxel for Second-Line Treatment of Non-small Cell Lung Cancer: A Real-World Cost-Effectiveness Analysis","year":2011,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; Canadian Centre for Applied Research in Cancer Control; University of British Columbia","funders":"","keywords":"Docetaxel; Erlotinib; Medicine; Oncology; Proportional hazards model; Internal medicine; Lung cancer; Hazard ratio; Population; Cost effectiveness; Survival analysis; Cancer; Epidermal growth factor receptor; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006579893,0.001863811,0.003906389,0.002123811,0.0003337452,0.002369672,0.001388077,0.001882513,0.006239195],"category_scores_gemma":[0.01448471,0.001041355,0.009825703,0.002319453,0.0007518246,0.002660729,0.0007702715,0.002459743,0.0002630512],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005449458,"about_ca_system_score_gemma":0.00197904,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01125274,"about_ca_topic_score_gemma":0.008102984,"domain_scores_codex":[0.9948457,0.003908017,0.0002432466,0.0003133062,0.0003107456,0.0003789155],"domain_scores_gemma":[0.9887481,0.009440207,0.0009510976,0.0002308911,0.0002191973,0.0004105082],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.36244,0.004847532,0.04332857,0.006278289,0.04595619,0.001112823,0.0001780445,0.4145508,0.002157319,0.004629759,0.004214128,0.1103066],"study_design_scores_gemma":[0.1009508,0.08074416,0.1296539,0.001701059,0.1344142,0.003247171,0.001208905,0.5285549,0.002880137,0.007755609,0.008188194,0.0007010931],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.964531,0.01686224,0.004756088,0.001400899,0.0001953306,0.0008581603,0.006978052,0.00008825038,0.004329906],"genre_scores_gemma":[0.9947252,0.001875096,0.001328042,0.0001968112,0.00004446513,0.0001459734,0.001316731,0.00001493398,0.0003526216],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01125274,"threshold_uncertainty_score":0.0395388,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06841015148918138,"score_gpt":0.4833870429544134,"score_spread":0.414976891465232,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}